Ruben Mesa, M.D.

January 12, 2023

Before closing out their program on myeloproliferative neoplasms, Rami Komrokji, MD, and Ruben Mesa, MD, discuss the potential for progression of MF to acute myeloid leukemia and highlight key treatment strategies.

January 05, 2023

Comprehensive discussion on the management of myelofibrosis, covering both monotherapy and combination therapy strategies.

January 05, 2023

Focusing on clinical trials and novel therapies, Rami Komrokji, MD, and Ruben Mesa, MD, share their hope for the future management of essential thrombocythemia and polycythemia vera.

December 29, 2022

Expert perspectives on the possible adverse events patients may encounter while receiving treatment for myeloproliferative neoplasms.